期刊文献+

大鼠骨髓间充质干细胞条件培养液促进心肌细胞肥大

Cardiomyocyte Hypertrophy Induced by Cultured Rat Mesenchymal Stem Cells Conditioned Medium
下载PDF
导出
摘要 体外模拟心肌缺血微环境,研究骨髓间充质干细胞(MSCs)的旁分泌作用对心肌细胞的影响。以大鼠MSCs各时间点的条件培养液刺激心肌细胞,观察心肌细胞蛋白含量、[3H]-Leu掺入、ANF-荧光素酶(luciferase)表达和心肌细胞面积的变化。MSCs条件培养液处理心肌细胞后,与对照组相比较6h及9h时间点的条件培养液可明显增加心肌细胞蛋白含量、[3H]-Leu掺入、ANF-荧光素酶表达以及心肌细胞面积,其中以6h时间点条件培养液的作用最为显著(P<0.01)。MSCs条件培养液能够通过旁分泌作用刺激心肌细胞肥大,此现象提示移植入心肌缺血区MSCs可能通过旁分泌作用影响心肌细胞,从而参与细胞移植后心功能的改善。 This study examined the hypertrophic effect of mesenchymal stem cells-conditioned medium (MSCs-CM) on neonatal rat cardiomyocytes. Rat MSCs were cultured with serum-free medium under hypoxic condition for 3 h, 6 h, 9 h and 24 h, and then the conditioned medium were collected separately. Cultured neonate rat cardiomyocytes were examined by ^3[H]-leucine incorporation, ANF-luciferase expression, F-actin staining and cell area measurement after stimulated with the above MSCs-CM for 48 h. Compared with control group, the total protein content, ^3[H]-leucine incorporation, ANF-luciferase expression and cell area were obviously increased in MSCs-CM stimulated groups. These results demonstrated that MSCs-CM induced cardiomyocyte hypertrophy in a paracrine manner and implied that this effect likely involved in the improvement of heart function after MSCs transplantation.
出处 《细胞生物学杂志》 CSCD 2007年第4期590-594,共5页 Chinese Journal of Cell Biology
基金 国家杰出青年科学基金资助项目(No.30400178)~~
关键词 骨髓间充质干细胞 条件培养液 心肌细胞 肥大 旁分泌 mesenchymal stem cells conditioned medium cardiomyocyte hypertrophy paracrine
  • 相关文献

参考文献2

二级参考文献13

  • 1刘先宝,王建安.骨髓间充质干细胞在心肌再生治疗中的免疫耐受现象及其机制[J].中国分子心脏病学杂志,2005,5(6):806-808. 被引量:1
  • 2[2]Kinnaird T, Stabile E, Burnett MS, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res ,2004,94 (5) :678-685.
  • 3[3]Wang JS, Shum-Tim D, Chedrawy E, et al. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg, 2001,122(4) :699-705.
  • 4[4]Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts,angiogenic ligands, and cytokines. Circulation,2001,104(9) :1046-1052.
  • 5[5]Weiquan Zhu JC, Xi Chen et al. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells, 2005 (in press).
  • 6[6]Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res,2004,95( 1 ) :9-20.
  • 7[7]Haynesworth SE, Goshima J, Goldberg VM, et al. Characterization of cells with osteogenic potential from human marrow. Bone, 1992,13 (1) :81-88.
  • 8[8]Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999,284 (5411 ):143-147.
  • 9[10]Dubey RK, Gillespie DG, Jackson EK. Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors.Hypertension, 1998,31 (4): 943 -948.
  • 10[12]Orlic D, KajsturaJ, Chimenti S, et al. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant,2003,7 Suppl 3:86-88.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部